Status:
ACTIVE_NOT_RECRUITING
Comparing the Reliability of Expressed Prostatic Secretion (EPS) and Post Massage Urine (PMU) for the Prediction of Prostate Cancer Biopsy Outcome
Lead Sponsor:
City of Hope Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Conditions Influencing Health Status
Healthy
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
This randomized pilot phase I trial studies the best way, either expressed prostatic secretion (EPS) or post massage urine (PMU) biomarkers, of predicting biopsy results in patients undergoing prostat...
Detailed Description
OBJECTIVES: I. To determine which non-invasive test for prostate cancer, EPS or PMU, is a better predictor of prostate cancer biopsy result. (Part I) II. To determine whether standardized testing fo...
Eligibility Criteria
Inclusion
- All men who will be undergoing transrectal ultrasound of the prostate (TRUSP) with biopsy in the department of Urology or participating urology clinics for the evaluation of prostate cancer
Exclusion
- Men with a previous diagnosis of prostate cancer
- Men without a prior diagnosis of prostate cancer but who have previously undergone a biopsy for a suspicious DRE or PSA
- Men with a prior diagnosis of cancer \< 5 years ago, excluding basal cell carcinoma and/or squamous cell carcinoma
Key Trial Info
Start Date :
July 14 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 9 2026
Estimated Enrollment :
243 Patients enrolled
Trial Details
Trial ID
NCT01441687
Start Date
July 14 2009
End Date
February 9 2026
Last Update
March 20 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinn & Chinn Urology Associates, Inc.
Arcadia, California, United States, 91006
2
City of Hope Medical Center
Duarte, California, United States, 91010
3
Citrus Valley Urologic Medical Group
Glendora, California, United States, 91741
4
Dr. Felix Chi-Ming Yip
Monterey Park, California, United States, 91754